Clinical Performance of a Chlorhexidine Antimicrobial Dressing

Solventum US LLC

Status and phase: Completed; Phase 3; Phase 2

Conditions: Catheterization

Treatments: Drug: Transparent Adhesive Dressing; Drug: Chlorhexidine gluconate

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00516906

05-010691

Details and patient eligibility

About

Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing

Full description

Prospective, controlled, randomized, clinical trial comparing the 3M™ TegadermTM CHG (Chlorhexidine Gluconate) IV Securement Dressing (3M Healthcare, St Paul, MN) to a standard transparent dressing.

Enrollment: 68 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males or Females over 18 years of age
• Patients with an existing, or newly inserted, central venous catheter
• Patients who require the catheter for at least 3 days

Exclusion criteria

• Sensitivity to chlorhexidine

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

68 participants in 2 patient groups, including a placebo group

Transparent Adhesive Dressing

Placebo Comparator group

Description:

Standard of Care Non-Antimicrobial Transparent Adhesive Dressing

Treatment:

Drug: Transparent Adhesive Dressing

CHG antimicrobial transparent dressing

Experimental group

Description:

Chlorhexidine gluconate antimicrobial transparent adhesive dressing

Treatment:

Drug: Chlorhexidine gluconate